About Ypsomed
Ypsomed is a company based in Burgdorf (Switzerland) founded in 2001 was acquired by Techmed in April 2025. Ypsomed has raised $7.45 million across 1 funding round from investors including BV Partners and TecMed Deutschland. The company has 2,640 employees as of March 31, 2024. Ypsomed offers products and services including Ypsomed Delivery Systems, Ypsomed Diabetescare, and YpsoPump. Ypsomed operates in a competitive market with competitors including Tandem Diabetes, Insulet, Valeritas, Kaleido and CeQur, among others.
- Headquarter Burgdorf, Switzerland
- Employees 2640 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ypsomed Holding Ag
-
Annual Revenue
$849.76 M (USD)36.54as on Mar 31, 2025
-
Net Profit
$99.29 M (USD)11.66as on Mar 31, 2025
-
EBITDA
$241.6 M (USD)36.55as on Mar 31, 2025
-
Total Equity Funding
$7.45 M (USD)
in 1 rounds
-
Latest Funding Round
$7.45 M (USD), Series A
Jun 01, 2003
-
Investors
BV Partners
& 1 more
-
Employee Count
2640
as on Mar 31, 2024
-
Acquired by
Techmed
(Apr 24, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ypsomed
Ypsomed is a publicly listed company on the SIX with ticker symbol YPSN in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Ypsomed
Ypsomed offers a comprehensive portfolio of products and services, including Ypsomed Delivery Systems, Ypsomed Diabetescare, and YpsoPump.
Technologies for reliable self-medication injection devices.
Products for easy diabetes self-treatment and monitoring.
Simple insulin pump system for diabetes management.
People of Ypsomed
Unlock access to complete
Unlock access to complete
Funding Insights of Ypsomed
Ypsomed has successfully raised a total of $7.45M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.45 million completed in June 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ypsomed
Ypsomed has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include BV Partners and TecMed Deutschland.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity financing is offered by BV Partners for businesses.
|
Locked | Locked | Locked | |
|
TecMed Deutschland GmbH is focused on producing insulin pump components.
|
Locked | Locked | Locked |
Investor details for Ypsomed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ypsomed
Investment portfolio details for Ypsomed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ypsomed
Detailed financials for Ypsomed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ypsomed Comparisons
Peer comparison for Ypsomed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ypsomed
Ypsomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tandem Diabetes, Insulet, Valeritas, Kaleido and CeQur, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of devices for continuous glucose monitoring and manual insulin delivery
|
|
| Locked | Locked | Locked |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| Locked | Locked | Locked |
Wearable insulin patch pumps are developed for transdermal delivery.
|
|
| Locked | Locked | Locked |
Insulin pumps and monitoring software for diabetes are developed.
|
|
| Locked | Locked | Locked |
Wearable insulin delivery patches are developed for mealtime dosing.
|
Detailed competitors of Ypsomed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ypsomed
Complete news archive for Ypsomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ypsomed
Ypsomed was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Ypsomed is headquartered in Burgdorf, Switzerland. It is registered at Burgdorf, Bern, Switzerland.
Ypsomed is a funded company, having raised a total of $7.45M across 1 funding round to date.
As of Mar 31, 2024, the latest employee count at Ypsomed is 2,640.
Annual revenue of Ypsomed is $849.76M as on Mar 31, 2025.
Ypsomed was founded in 2001 in Burgdorf, Switzerland, where injection systems for self-medication and diabetes care products are developed and manufactured. The portfolio encompasses blood glucose monitoring systems, pen needles, safety devices, and infusion systems. Operations focus on the medical device sector, supplying tools for diabetes management and self-administration across global markets.
Ypsomed's top competitors include Tandem Diabetes, Insulet and Kaleido.
Ypsomed offers Ypsomed Delivery Systems, Ypsomed Diabetescare, and YpsoPump.
Yes, Ypsomed is publicly traded on SIX under the ticker symbol YPSN.
Ypsomed has 2 investors. Key investors include BV Partners, and TecMed Deutschland.
The ticker symbol of Ypsomed is YPSN on SIX.